As the field of microfluidics and lab-on-a-chip technology rapidly advances, it is enabling innovative new diagnostic tools that are moving healthcare closer to the point-of-care. These miniaturized devices, often referred to as biochips, can perform complex laboratory analyses and medical tests using extremely small fluid volumes and portable equipment. With their small size, low cost, fast results and ease of use, biochips hold great promise to revolutionize healthcare and make powerful diagnostics widely available outside of traditional laboratory settings.
What are Lab-on-a-chip and Microarray Biochips?
Lab-on-a-chip or microfluidic biochips mimic traditional laboratory processes and fluid flow on a tiny, usually micrometer-scale integrated circuit chip. These miniaturized “labs” can analyze chemical, biochemical and biological materials on millimeter-sized chambers and fluidic channels. Depending on their application, biochips may integrate various functions like sample preparation, detection and analysis. Microarray biochips involve miniaturizing techniques such as DNA microarrays, Western blotting, and protein peptide arrays to allow analyzing thousands of biomolecular interactions simultaneously.
Applications in Point-of-Care Diagnostics
Lab-on-a-chip technology is finding a wide array of biomedical applications in areas like disease diagnostics, drug screening and toxicity testing. Perhaps one of the most promising uses is for rapid, low-cost point-of-care diagnostic testing. By consolidating sample-in to result-out processes on a single chip, biochips are ideal for applications such as bedside or home medical testing that do not require centralized laboratory facilities or highly trained personnel. Some key point-of-care applications include:
- Infectious Disease Testing - Biochips can test clinical samples for viruses, bacteria or other pathogens in a matter of minutes versus hours or days. This enables fast diagnosis and treatment decisions for diseases like HIV, flu, tuberculosis and sepsis.
- Blood Analysis - Biochips can efficiently analyze blood components like cells, proteins, enzymes and metabolites to screen for conditions like anemia, kidney disorders and metabolic diseases. Portable haematology analyzers using biochip technology are now available.
- Cardiac Marker Testing - Biochips can rapidly detect markers for heart attack like troponin levels from a finger-prick worth of blood, helping paramedics triage patients in the field.
- Cancer Screening - Microarray biochips can examine tumor marker levels, genetic mutations and protein expression patterns to aid cancer diagnosis and monitoring.
Advantages Over Traditional Methods
Biochips offer several advantages over standard laboratory diagnostic methods:
Miniaturization - Lab-On-A-Chip And Microarrays benchtop laboratory equipment, reagents and processes onto a single, handheld microchip that requires very small sample volumes in the range of microliters or less.
Low Cost - Integrating several diagnostic steps on a single chip reduces costs by minimizing expensive equipment, reagents and technician time required. Mass production further cuts unit costs to just a few dollars per test.
Rapidity - Automated biochip processes can return results in minutes instead of hours or days. Sample-to-result times are faster due to short diffusion lengths, rapid mixing at the microscale and high surface area-to-volume ratios.
Simple Operation - Biochips are designed for ease-of-use with basic skills. Lay users can perform point-of-care tests via integrated fluid handling, incubation, detection and readout without special training.
Portability - Small, lightweight, self-contained biochip devices can perform complex assays outside central labs, at the bedside, in clinics, remote areas and even homes. This improves accessibility.
Standardization - Integrated fluidics and mechanics standardize each biochip assay and produce consistent, reproducible results eliminating technician-to-technician variability.
Commercialization and Future Outlook
With the above advantages, microfluidic and biochip technology is gaining commercial acceptance. Major diagnostic firms are marketing biochip-based platforms and tests for detection of diseases like influenza, HIV and cancer. Portable and handheld biochip devices for telemedicine and home healthcare are in development stages. Future advancements like 3D printing and flexible, paper-based biochips promise even more widespread application beyond medical settings. Overall, as the technology matures, lab-on-a-chip is set to revolutionize diagnostics and bring sophisticated medical testing to the point-of-care. This will significantly benefit global healthcare by enabling faster, cheaper and more accessible diagnostic services where they are needed most.
For More details on the topic:
https://www.newswirestats.com/lab-on-a-chip-and-microarrays-size-and-share-analysis/
Market InsightsAccording to the reports published by Market Research Future, the global lab-on-a-chip device market is projected to exhibit robust growth with registering a CAGR of 10% by the year 2023.
The lab-on-a-chip device brings diverse laboratory processes on a minimally sized integrated circuit and thus, eases the sample handling process and delivers results with excellent efficiency.Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6215With that, quick sampling with precise results within a short span of time can easily solve problems such as drug wastage as well as drug resistance.
Therefore, lab-on-a-chip offers optimization of the process and gains traction in various corners of the pharmaceutical sector.
Similarly, other factors such as multiple advantages of microfluidic technology, rise in demand for diagnostics, expanding global population with the prediction of significant growth opportunities, and technological advancements in laboratories have amplified the penetration and growth of the lab-on-chips market globally.
By the mode of technology, the market is segmented into microarrays, microfluidics, tissue biochip, and others.By the mode of the application, the market is segmented into genomics, proteomics, the point of care diagnostics, drug discovery, and others.Lastly, accounting on the end-user, the market is segmented as hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.Regional OutlookOn a geographical note, the global lab-on-a-chip device market has covered the main regions of America, Europe, Asia Pacific, and the Middle East & Africa.Among all, the Americas is the market leader and has an attractive lab-on-a-chip devices market growth owing to mounting advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases.
According to stats by the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine.
Lab-on-a-Chip Device research report includes specific segments by region (country), by company, by Type and by Application.
This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.
Understanding the segments helps in identifying the importance of different factors that aid the market growth.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-labonachip-device-2021-418Segment by TypeMicroarraysMicrofluidicsTissue BiochipOthersSegment by ApplicationHospitals and ClinicsBiotechnology and Pharmaceutical CompaniesForensic LaboratoriesAcademic & Research InstitutesBy RegionNorth AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaTaiwanIndonesiaThailandMalaysiaPhilippinesVietnamLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaU.A.EBy CompanyBDAgilent TechnologiesDanaherBio-RadAbbott LaboratoriesRochePerkinElmerIDEXThermo Fisher ScientificCepheid Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-labonachip-device-2021-418Table of content1 Lab-on-a-Chip Device Market Overview1.1 Product Overview and Scope of Lab-on-a-Chip Device1.2 Lab-on-a-Chip Device Segment by Type1.2.1 Global Lab-on-a-Chip Device Sales Growth Rate Comparison by Type (2021-2027)1.2.2 Microarrays1.2.3 Microfluidics1.2.4 Tissue Biochip1.2.5 Others1.3 Lab-on-a-Chip Device Segment by Application1.3.1 Lab-on-a-Chip Device Sales Comparison by Application: (2021-2027)1.3.2 Hospitals and Clinics1.3.3 Biotechnology and Pharmaceutical Companies1.3.4 Forensic Laboratories1.3.5 Academic & Research Institutes1.4 Global Lab-on-a-Chip Device Market Size Estimates and Forecasts1.4.1 Global Lab-on-a-Chip Device Revenue 2016-20271.4.2 Global Lab-on-a-Chip Device Sales 2016-20271.4.3 Lab-on-a-Chip Device Market Size by Region: 2016 Versus 2021 Versus 20272 Lab-on-a-Chip Device Market Competition by Manufacturers2.1 Global Lab-on-a-Chip Device Sales Market Share by Manufacturers (2016-2021)2.2 Global Lab-on-a-Chip Device Revenue Market Share by Manufacturers (2016-2021)2.3 Global Lab-on-a-Chip Device Average Price by Manufacturers (2016-2021)2.4 Manufacturers Lab-on-a-Chip Device Manufacturing Sites, Area Served, Product Type2.5 Lab-on-a-Chip Device Market Competitive Situation and Trends2.5.1 Lab-on-a-Chip Device Market Concentration Rate2.5.2 The GlobalIf You Have Any Question Related To This Report Contact Us @ https://www.grandresearchstore.com/enquire-now/global-labonachip-device-2021-418CONTACT US:276 5th Avenue, New York, NY 10001, United StatesInternational: +1(646)-781-7170 / +91 8087042414Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/grand-research-store
